Vitamin D deficiency is the most commonly diagnosed gap in GLP-1 users, and low iron is a frequent finding as well
Monitoring Matters Monitor: Renal function Electrolytes Heart rate Serum digoxin concentration when clinically indicated Antidote Available Severe toxicity can be treated with Digoxin Immune Fab( a life-saving antidote.) Digoxin is a 200-Year-Old Drug Still Have a Place in Modern Medicine #Digoxin #Cardiology #HeartFailure #AtrialFibrillation #ClinicalPharmacy #Pharmacology #InternalMedicine #PatientSafety #EvidenceBasedMedicine #Healthcare To view or add a comment, sign in FDA Approval Update | Hypertension Management The U.S
The conditions we treat most frequently with BPC-157 in this category include Achilles tendinopathy, patellar tendinitis, lateral epicondylitis (tennis elbow), rotator cuff partial tears, partial ACL and MCL tears, and chronic ankle instability
On April 30, 2026, the FDA announced a proposal to exclude semaglutide, tirzepatide, and liraglutide from the 503B compounding bulks list - the regulatory mechanism that has governed large-scale compounded GLP-1 production
Future research is expected to shed more light into the potential benefits and uses of this NNMT inhibitor
Nat Rev Gastroenterol Hepatol 23 , 475492 (2026)
.png)
